Cancer Genetics Reports Record Q3 Revenue

Precision medicine for oncology firm Cancer Genetics (CGI) today reported its third quarter results for 2017. According to the company, total revenues were $8.0 million—up 19% over Q3 2016 revenues of $6.8 million—with $4.2 million from biopharma services (up 10% since the same period last year), $2.9 million from clinical services (up 7%) and $1.0 million from discovery services (up 280%). “We are pleased to have delivered a record quarter of revenue along with a signific